TY - JOUR
T1 - iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy
AU - Lynch, Lydia
AU - Hogan, Andrew E.
AU - Duquette, Danielle
AU - Lester, Chantel
AU - Banks, Alexander
AU - LeClair, Katherine
AU - Cohen, David E.
AU - Ghosh, Abhisek
AU - Lu, Bing
AU - Corrigan, Michelle
AU - Stevanovic, Darko
AU - Maratos-Flier, Eleftheria
AU - Drucker, Daniel J.
AU - O'Shea, Donal
AU - Brenner, Michael
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/9/13
Y1 - 2016/9/13
N2 - Adipose-resident invariant natural killer T (iNKT) cells are key players in metabolic regulation. iNKT cells are innate lipid sensors, and their activation, using their prototypic ligand α-galactosylceramide (αGalCer), induces weight loss and restores glycemic control in obesity. Here, iNKT activation induced fibroblast growth factor 21 (FGF21) production and thermogenic browning of white fat. Complete metabolic analysis revealed that iNKT cell activation induced increased body temperature, V02, VC02, and fatty acid oxidation, without affecting food intake or activity. FGF21 induction played a major role in iNKT cell-induced weight loss, as FGF21 null mice lost significantly less weight after αGalCer treatment. The glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, also activated iNKT cells in humans and mice. In iNKT-deficient mice, liraglutide promoted satiety but failed to induce FGF21, resulting in less weight loss. These findings reveal an iNKT cell-FGF21 axis that defines a new immune-mediated pathway that could be targeted for glycemic control and weight regulation.
AB - Adipose-resident invariant natural killer T (iNKT) cells are key players in metabolic regulation. iNKT cells are innate lipid sensors, and their activation, using their prototypic ligand α-galactosylceramide (αGalCer), induces weight loss and restores glycemic control in obesity. Here, iNKT activation induced fibroblast growth factor 21 (FGF21) production and thermogenic browning of white fat. Complete metabolic analysis revealed that iNKT cell activation induced increased body temperature, V02, VC02, and fatty acid oxidation, without affecting food intake or activity. FGF21 induction played a major role in iNKT cell-induced weight loss, as FGF21 null mice lost significantly less weight after αGalCer treatment. The glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, also activated iNKT cells in humans and mice. In iNKT-deficient mice, liraglutide promoted satiety but failed to induce FGF21, resulting in less weight loss. These findings reveal an iNKT cell-FGF21 axis that defines a new immune-mediated pathway that could be targeted for glycemic control and weight regulation.
UR - http://www.scopus.com/inward/record.url?scp=84990848453&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84990848453&partnerID=8YFLogxK
U2 - 10.1016/j.cmet.2016.08.003
DO - 10.1016/j.cmet.2016.08.003
M3 - Article
C2 - 27593966
AN - SCOPUS:84990848453
SN - 1550-4131
VL - 24
SP - 510
EP - 519
JO - Cell Metabolism
JF - Cell Metabolism
IS - 3
ER -